{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T01:54:38Z","timestamp":1774662878272,"version":"3.50.1"},"reference-count":34,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2007,4,28]],"date-time":"2007-04-28T00:00:00Z","timestamp":1177718400000},"content-version":"vor","delay-in-days":4135,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Allergy"],"published-print":{"date-parts":[[1996,1]]},"abstract":"<jats:p>The prevalence of atopy was evaluated in two groups of subjects with hypersensitivity to nonsteroidal anti\u2010inflammatory drugs (NSAID):<\/jats:p><jats:p>\n<jats:list list-type=\"explicit-label\">\n<jats:list-item><jats:p>78 patients with aspirin\u2010induced asthma (AIA) confirmed by oral or bronchial provocation challenges<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>42 subjects with hypersensitivity to pyrazolone drugs (case history and positive skin tests to noramidopyrine\/aminophenazone) who tolerated aspirin well.<\/jats:p><\/jats:list-item>\n<\/jats:list>\n<\/jats:p><jats:p>Fifty sex\u2010 and age\u2010matched persons from an unselected general population, with no hypersensitivity to NSAID, formed the control group. Atopy was estimated from the results of the following clinical and biologic parameters:<\/jats:p><jats:p>\n<jats:list list-type=\"explicit-label\">\n<jats:list-item><jats:p>1) personal and family history of atopic diseases<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>2) skin prick tests with 16 aeroallergens<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>3) serum levels of specific IgE to five aeroallergens<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>4) total serum IgE level.<\/jats:p><\/jats:list-item>\n<\/jats:list>\n<\/jats:p><jats:p>Different definitions of atopy were used, consisting of constellations of two or three of the above\u2010mentioned features. The results of the study revealed that the prevalence of atopy varied according to the criteria used for its definition. Irrespective of the definition used, a similar distribution of atopy was observed in both groups of patients with hypersensitivity to NSAID. Atopy was more frequent in either group of patients with intolerance of NSAID than in the control group. Thus, atopy is related to adverse drug reactions to NSAID.<\/jats:p>","DOI":"10.1111\/j.1398-9995.1996.tb04544.x","type":"journal-article","created":{"date-parts":[[2008,4,30]],"date-time":"2008-04-30T10:27:58Z","timestamp":1209551278000},"page":"16-23","source":"Crossref","is-referenced-by-count":33,"title":["The atopy trait in hypersensitivity to nonsteroidal anti\u2010inflammatory drugs"],"prefix":"10.1111","volume":"51","author":[{"given":"G.","family":"Bochenek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Ni\u017cankowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Szczeklik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,4,28]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.1990.tb00489.x"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(77)90106-3"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.1981.tb01842.x"},{"key":"e_1_2_1_5_2","first-page":"233","volume-title":"Asthma: basic mechanisms and thcrapeutic perspectives","author":"Szczeklik A.","year":"1989"},{"key":"e_1_2_1_6_2","first-page":"762","volume-title":"Allergologie","author":"Szczeklik A.","year":"1992"},{"key":"e_1_2_1_7_2","first-page":"470","article-title":"Acetylsalicylic acid allergy and pyrazolone allergy and pseudoallergy? Results of the skin tests and antibody determinants in a multi\u2010center study","volume":"62","author":"Fabro L.","year":"1987","journal-title":"Z Hautkr"},{"key":"e_1_2_1_8_2","first-page":"253","volume-title":"100 Jahre Pyrazolone \u2010 eine Bestandsaufname","author":"Virchow C.","year":"1985"},{"key":"e_1_2_1_9_2","first-page":"253","volume-title":"100 Jahre Pyrazolone \u2010 eine Bestandsaufname","author":"Voigtl\u00e4nder V.","year":"1985"},{"key":"e_1_2_1_10_2","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1183\/09031936.93.06030391","article-title":"Cysteinyl leukotrienes overproduction and mast cell activation in aspirin\u2010provoked bron\u2010chospasm and asthma","volume":"6","author":"Sladek K.","year":"1993","journal-title":"Eur Respir J"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)90286-3"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.1994.tb00830.x"},{"key":"e_1_2_1_13_2","first-page":"320","article-title":"Tolerance of pyrazolidine derivative azapropa\u2010zone in hypersensitivity to pyrazolone drugs","volume":"3","author":"Nizankowska E.","year":"1994","journal-title":"Allergo J"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.1980.tb01796.x"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)92687-1"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(84)90363-4"},{"key":"e_1_2_1_17_2","unstructured":"SchwarzM.Heredity in bronchial asthma.Acta Allergol1952;5 Suppl2121\u20136."},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-68-5-975"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1080\/21548331.1973.11707951"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-71-3-479"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(74)90080-3"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(73)90030-4"},{"key":"e_1_2_1_23_2","first-page":"157","volume-title":"NSAIDs \u2010 a profile of adverse effects","author":"Hoigne RV","year":"1992"},{"key":"e_1_2_1_24_2","volume-title":"Drug allergy","author":"Vervloet D.","year":"1992"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1991.tb03203.x"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.1993.tb04761.x"},{"key":"e_1_2_1_27_2","first-page":"21","volume-title":"Diagnosis and treatment of IgE\u2010mediated diseases","author":"Johansson SGO.","year":"1980"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.1988.tb00410.x"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.1981.tb01871.x"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.94102302"},{"key":"e_1_2_1_31_2","first-page":"277","article-title":"Lack of specific IgE against house dust and Dermatophagoides pteronyssinus in aspirin\u2010sensitive asthmatics with positive skin and inhalation test","volume":"10","author":"Swatko A.","year":"1982","journal-title":"Allergol Immunopathol (Madr)"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.8178175"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)93057-0"},{"key":"e_1_2_1_34_2","unstructured":"DekkerJW PileK. NizankowskaE. Schmitz\u2010SchumannM. et al.Aspirin\u2010induced asthma and HLA\u2010DRBI and HLA\u2010DPBI genotypes.Am J Respir Crit Care Med(in press)."},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(93)90045-H"}],"container-title":["Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1398-9995.1996.tb04544.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1398-9995.1996.tb04544.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T12:39:07Z","timestamp":1698410347000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1398-9995.1996.tb04544.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1996,1]]}},"alternative-id":["10.1111\/j.1398-9995.1996.tb04544.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1398-9995.1996.tb04544.x","archive":["Portico"],"relation":{},"ISSN":["0105-4538","1398-9995"],"issn-type":[{"value":"0105-4538","type":"print"},{"value":"1398-9995","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,1]]}}}